San Clemente, CA, April 13, 2021 (GLOBE NEWSWIRE) via NewMediaWire Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease. "This could simply be described as nothing short of a Medical Breakthrough in Parkinson's Disease Diagnostic Testing for us." said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP). Global WholeHealth Partners now has the means to identify and test for Parkinson’s disease using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis. This was disclosed in an 8K filing which can be found by clicking here. Filed on 03/21/2021 “We believe this announcement couldn’t come at a better time for us as we are right in the middle of Parkinson’s Awareness Month,” said Mr. Strongo. “I just read an artic